Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-184432
Filing Date
2025-08-21
Accepted
2025-08-20 20:30:41
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-3 d56842ds3.htm S-3 477271
2 EX-5.1 d56842dex51.htm EX-5.1 26061
3 EX-23.2 d56842dex232.htm EX-23.2 2002
4 EX-23.3 d56842dex233.htm EX-23.3 1996
5 EX-FILING FEES d56842dexfilingfees.htm   iXBRL EX-FILING FEES 34006
6 GRAPHIC g56842g03x03.jpg GRAPHIC 46817
  Complete submission text file 0001193125-25-184432.txt   762740

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d56842dexfilingfees_htm.xml XML 16042
Mailing Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301
Business Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289748 | Film No.: 251238205
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)